Paricalcitol
Paricalcitol is a selective vitamin D receptor agonist used to manage secondary hyperparathyroidism in chronic kidney disease. It is widely employed in renal research, with studies demonstrating its effects on parathyroid hormone suppression in both in vitro cell models and in vivo animal studies of renal failure.
Product Specifications
CAS Number
131918-61-1
Product Name Alternative
Inhibitor, Paricalcitol, inhibit, VD/VDR, Vitamin D receptor, vitamin D receptor, Vitamin D
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
98.59% (May vary between batches)
Solubility
Ethanol:12 mg/mL (28.8 mM) ;10% DMSO+90% Corn Oil:3.3 mg/mL (7.92 mM) ; H2O:Insoluble; DMSO:140 mg/mL (336.02 mM)
Smiles
[H][C@@]12CC[C@H] ([C@H] (C) \C=C\[C@H] (C) C (C) (C) O) [C@@]1 (C) CCC\C2=C/C=C1C[C@@H] (O) C[C@H] (O) C1
Molecular Formula
C27H44O3
Molecular Weight
416.64
Storage Conditions
Powder: -20°C for 3 years | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Junction Mediating and Regulatory Protein (JMY) Blocking Peptide
Junction Mediating and Regulatory Protein (JMY) Blocking Peptide
